ABBVIE (ABBV) Earnings Date & Reports

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta)... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ABBV is expected to report earnings to rise 20.33% to $2.96 per share on July 31

Q2'25

Est.

$2.96

Q1'25

Beat

by $0.07

Q4'24

Beat

by $0.10

Q3'24

Beat

by $0.08

Q2'24

Missed

by $0.05

The last earnings report on April 25 showed earnings per share of $2.46, beating the estimate of $2.39. With 4.95M shares outstanding, the current market capitalization sits at 322.43B.

View a ticker or compare two or three

Compare

Day Trader: Search for Dip TA&FA ($1500)Day Trader: Search for Dip TA&FA ($1500)

Annualized Return+10%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

ABBV